ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      -0.19%
      US Tech 100
      19,287.60
      -0.24%
      Dow Jones
      42,063.36
      0.09%
      Brent Oil
      74.405
      0.70%
      Bitcoin
      63,803.06
      0.28%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Werewolf Therapeutics Inc (HOWL) Quote

      Werewolf Therapeutics Inc

      Werewolf Therapeutics Inc (HOWL)

      NASDAQ
      2.19
      -0.21
      (-8.75%)
      Closed September 22 4:00PM
      Delayed by 15 minutes
      2.19
      0.00
      (0.00%)
      After Hours: 7:22PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      2.19
      Bid
      1.71
      Ask
      3.50
      Volume
      347,457
      2.14 Day's Range 2.40
      1.5735 52 Week Range 8.1939
      Market Cap
      95.708M
      Previous Close
      2.40
      Open
      2.38
      Last Trade
      112
      @
      2.19
      (formt)
      Last Trade Time
      Financial Volume
      $ 809,821
      VWAP
      2.3307
      Average Volume (3m)
      275,453
      Shares Outstanding
      43,702,147
      Dividend Yield
      -
      PE Ratio
      -2.56
      Earnings Per Share (EPS)
      -0.86
      Revenue
      19.94M
      Net Profit
      -37.37M

      About Werewolf Therapeutics Inc

      Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      werewolftx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Werewolf Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HOWL. The last closing price for Werewolf Therapeutics was $2.40. Over the last year, Werewolf Therapeutics shares have traded in a share price range of $ 1.5735 to $ 8.1939.

      Werewolf Therapeutics currently has 43,702,147 shares outstanding. The market capitalization of Werewolf Therapeutics is $104.89 million. Werewolf Therapeutics has a price to earnings ratio (PE ratio) of -2.56.

      Ask ADVFN Intelligence (AI)

      HOWL Latest News

      More News

      Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

      WATERTOWN, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development...

      September 03 2024
      GlobeNewswire Inc.

      Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

      August 08 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 08 2024
      Edgar (US Regulatory)

      Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

      – Positive data from ongoing Phase 1/1b clinical trial of WTX-124 presented at American Society of Clinical Oncology (ASCO) Annual Meeting – – Encouraging signs of clinical activity at tolerable...

      August 08 2024
      GlobeNewswire Inc.

      Werewolf Therapeutics Highlights Initial Safety and Efficacy Data from its Ongoing Phase 1 Clinical Trial Evaluating WTX-330 in Patients with Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma

      - Data demonstrate that administration of WTX-330 reached therapeutically relevant exposure levels of systemically delivered IL-12 prodrug with an improved tolerability profile over historical...

      June 25 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      June 03 2024
      Edgar (US Regulatory)

      Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors

      -  WTX-124 was shown to be clinically active and generally well-tolerated in patients who were relapsed/refractory to immune checkpoint inhibitor therapy - -  Encouraging single agent clinical...

      June 01 2024
      GlobeNewswire Inc.

      Werewolf Therapeutics to Participate at the Jefferies Global Healthcare Conference

      WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of...

      May 30 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      May 28 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.02-0.9049773755662.212.4522.0851211642.24073337CS
      4-0.03-1.351351351352.222.71.911425952.26930856CS
      12-0.28-11.33603238872.473.071.662754532.35917589CS
      26-3.78-63.31658291465.976.891.662422043.37369187CS
      52-0.31-12.42.58.19391.57354137543.48690807CS
      156-15.31-87.485714285717.518.221.392345104.14575542CS
      260-16.02-87.973640856718.2123.991.392240424.97381623CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BNZIBanzai International Inc
      $ 5.645
      (96.01%)
      		61.39M
      ZJYLJin Medical International Ltd
      $ 3.975
      (50.00%)
      		1.24M
      ANEBAnebulo Pharmaceuticals Inc
      $ 2.9001
      (39.43%)
      		78.85k
      XPONExpion360 Inc
      $ 0.081
      (39.18%)
      		1.46B
      AENTAlliance Entertainment Holding Corporation
      $ 2.74
      (34.31%)
      		4.23M
      GSIWGarden Stage Ltd
      $ 1.34
      (-82.89%)
      		26.44M
      CRBPCorbus Pharmaceuticals Holdings Inc
      $ 19.51
      (-62.26%)
      		12.29M
      LGCBLinkage Global Inc
      $ 0.4183
      (-57.70%)
      		2.16M
      BFIBurgerFi International Inc
      $ 0.0855
      (-42.27%)
      		15.05M
      SKYESkye Bioscience Inc
      $ 3.17
      (-42.26%)
      		5.14M
      XPONExpion360 Inc
      $ 0.081
      (39.18%)
      		1.46B
      NVDANVIDIA Corporation
      $ 116.00
      (-1.59%)
      		378.16M
      AAPLApple Inc
      $ 228.20
      (-0.29%)
      		320.24M
      INTCIntel Corporation
      $ 21.84
      (3.31%)
      		261.68M
      VERBVerb Technology Company Inc
      $ 0.0742
      (33.45%)
      		178.65M

      HOWL Discussion

      View Posts
      Monksdream Monksdream 3 weeks ago
      HOWL under $3
      👍️0
      Monksdream Monksdream 2 months ago
      HOWL under $3
      👍️0
      Monksdream Monksdream 5 months ago
      HOWL under $10
      👍️0
      Monksdream Monksdream 9 months ago
      HOWL new 52 week high
      👍️0
      Pt3 Pt3 11 months ago
      Yea your gap and trapped make me buy caud instead of this
      👍️0
      TheFinalCD TheFinalCD 11 months ago
      HOWL todays algo patented Gap & Trap on Phase #1 news
      👍️0
      TheFinalCD TheFinalCD 11 months ago
      Werewolf Therapeutics soars 52% premarket after presentsing preliminary monotherapy data from Phase 1/1b clinical trial establishing proof of mechanism for WTX-124$HOWL#AInvest #Ainvest_Wire #trade #source #wallstreet
      View more: https://t.co/aTzfU7GqUS pic.twitter.com/rClSWzl2IS— AInvest Wire (@Ainvest_Wire) November 3, 2023
      👍️0
      TheFinalCD TheFinalCD 11 months ago
      $howl flying https://finviz.com/quote.ashx?t=HOWL&ty=c&ta=1&p=d

      https://dilutiontracker.com/app/search/HOWL
      👍️0
      tw0122 tw0122 11 months ago
      $3 + otw Halloween is here give it a HOWL
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      https://stockcharts.com/h-sc/ui?s=howl&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      https://stockcharts.com/h-sc/ui?s=howl&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      dip
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      dip
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      watching
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      soon
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      insert dd
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      can be big
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      wow
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      wow
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      hold
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      slow
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      slow
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      agreed
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      like thiks
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      off radar
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      catchy name
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      catchy name
      👍️0
      surf1944 surf1944 1 year ago
      https://stockcharts.com/h-sc/ui?s=howl&p=D&yr=0&mn=6&dy=0&id=p38090673899

      https://www.barchart.com/stocks/quotes/howl/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

      https://www.barchart.com/stocks/quotes/howl/opinion
      👍️0
      Mr. Zen Mr. Zen 2 years ago
      Watch list addition, this has the potential to run, just waiting for all the pieces of the puzzle to come together.

      “These promising preclinical data add to a growing body of evidence demonstrating the potential of WTX-330 to drive targeted anti-tumor immune responses selectively in the tumor microenvironment (TME),” said Cynthia Seidel-Dugan, Ph.D., Chief Scientific Officer of Werewolf Therapeutics. “This morning, in our Third Quarter 2022 release, we announced that the FDA has granted clearance of the investigational new drug (IND) application for WTX-330. We are excited to advance WTX-330 into the clinic and to continue developing a pipeline of novel proinflammatory cytokine therapies that have the potential to change the lives of cancer patients.”
      👍️0
      makinezmoney makinezmoney 2 years ago
      $HOWL: Hey thanks....... now 3.20.

      Only getting better right ??


      Enjoy those profits.





      GO $HOWL
      👍️0
      Makk1 Makk1 2 years ago
      Good call here, looking very good
      👍️0
      makinezmoney makinezmoney 2 years ago
      $HOWL: Looks like its turning...... now 2.25

      Let see if volume pushes it up.


      The setup is nice


      GO $HOWL
      👍️0
      bobbo5 bobbo5 2 years ago
      I agree and it looks like share price has been moving up this past week
      👍️0
      dia76ca dia76ca 2 years ago
      Very interesting company. I like it's chances.
      👍️0

      Your Recent History

      NASDAQ
      HOWL
      Werewolf Therapeutics
      Delayed Upgrade Clock